Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery

Pharmacology, Toxicology and Pharmaceutical Science

• Statin (Protein) 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 65%
• Placebo 25%
• Controlled Clinical Trial 20%
• Atherosclerosis 15%
• Adverse Event 15%
• Heart Infarction 15%
• Population Study 10%
• Atorvastatin 10%
• Myalgia 10%
• Cardiovascular Disease 5%
• Comorbidity 5%
• Syndrome 5%
• Combination Therapy 5%
• Vascular Disease 5%
• Hypercholesterolemia 5%
• Cardiovascular Risk 5%
• Nausea 5%
• Muscle Enzyme 5%
• Peroperative Complication 5%